Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.3% |
| 2 | Financials | 14.49% |
| 3 | Healthcare | 13.31% |
| 4 | Industrials | 10.23% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Eaton
ETN
$153B
| $328M | 0.18% |
3,461,252
-70,763
| -2% | -$6.28M |
|
102
Digital Realty Trust
DLR
$66.5B
| $324M | 0.17% |
2,705,864
+78,099
| +3% | +$9.61M |
|
103
PNC Financial Services
PNC
$96.8B
| $323M | 0.17% |
2,024,095
-51,736
| -2% | -$7.77M |
|
104
Becton Dickinson
BDX
$49.8B
| $319M | 0.17% |
1,200,598
+22,036
| +2% | +$5.49M |
|
105
Morgan Stanley
MS
$324B
| $313M | 0.17% |
6,127,906
-6,719
| -0.1% | -$318K |
|
106
Prudential Financial
PRU
$41.2B
| $312M | 0.17% |
3,330,508
+65,732
| +2% | +$6.04M |
|
107
Boston Properties
BXP
$10.3B
| $312M | 0.17% |
2,261,193
+147,291
| +7% | +$19.8M |
|
108
CME Group
CME
$101B
| $310M | 0.17% |
1,545,958
+24,903
| +2% | +$5.11M |
|
109
Chubb
CB
$132B
| $310M | 0.17% |
1,989,991
+22,692
| +1% | +$3.47M |
|
110
Duke Energy
DUK
$92.8B
| $308M | 0.17% |
3,380,054
+70,139
| +2% | +$6.43M |
|
111
Stryker
SYK
$108B
| $308M | 0.17% |
1,466,020
+28,434
| +2% | +$5.9M |
|
112
Southern Company
SO
$100B
| $302M | 0.16% |
4,746,882
+63,358
| +1% | +$3.93M |
|
113
SLB Ltd
SLB
$79.1B
| $301M | 0.16% |
7,476,114
+209,827
| +3% | +$7.49M |
|
114
S&P Global
SPGI
$123B
| $300M | 0.16% |
1,099,039
+7,346
| +0.7% | +$1.91M |
|
115
Dominion Energy
D
$56.7B
| $298M | 0.16% |
3,597,980
+42,564
| +1% | +$3.48M |
|
116
Intuit
INTU
$90.6B
| $297M | 0.16% |
1,132,200
-25,016
| -2% | -$6.54M |
|
|
FISV
117
Fiserv Inc
FISV
$27.1B
| $296M | 0.16% |
2,564,130
+40,867
| +2% | +$4.51M |
|
118
Intuitive Surgical
ISRG
$134B
| $293M | 0.16% |
1,486,407
+32,295
| +2% | +$6.05M |
|
|
RTN
119
DELISTED
Raytheon Company
RTN
| $284M | 0.15% |
1,291,266
+17,228
| +1% | +$3.64M |
|
120
Ventas
VTR
$45.7B
| $283M | 0.15% |
4,900,683
+172,954
| +4% | +$10.9M |
|
121
MetLife
MET
$62.1B
| $283M | 0.15% |
5,544,520
-59,724
| -1% | -$2.88M |
|
122
Biogen
BIIB
$32.1B
| $277M | 0.15% |
934,331
-33,539
| -3% | -$9.31M |
|
123
Zoetis
ZTS
$30.4B
| $277M | 0.15% |
2,093,741
-46,272
| -2% | -$5.75M |
|
|
AGN
124
DELISTED
Allergan plc
AGN
| $274M | 0.15% |
1,432,978
+23,936
| +2% | +$4.32M |
|
125
General Mills
GIS
$19.5B
| $274M | 0.15% |
5,113,755
+123,371
| +2% | +$6.5M |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.